GlassScriptPhysician profile
Lawrence W Blass
NPI 1356632335
$5,560.32
in general payments reported to CMS, 2019-2025
21 companies · $391 in 2025
The $391 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,111 · 2020: $130 · 2021: $590 · 2022: $674 · 2023: $265 · 2024: $401 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,056.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,689.58 | 2019 | |
| Boston Scientific Corporation | $905.22 | 2020-2025 | Overstitch Endoscopic Suturing System, Apollo Revise Nxt System, Spyglass |
| Allergan, INC. | $815.24 | 2019 | |
| Zimmer Biomet Holdings, INC. | $576.19 | 2019-2022 | |
| Medtronic, INC. | $516.10 | 2021-2025 | Closurefast, Progrip, Venaseal |
| Intuitive Surgical, INC. | $271.91 | 2021-2022 | |
| Tela Bio, INC. | $195.30 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Organogenesis INC. | $108.70 | 2023-2025 | Via Matrix, Puraply |
| Smith+Nephew, INC. | $102.12 | 2019 | |
| Dilon Technologies, INC. | $94.15 | 2024 | Hemoblast Bellows |
| Ethicon US, LLC | $63.06 | 2019-2020 | |
| Davol INC. | $50.14 | 2020-2025 | Phasix Mesh |
| Convatec INC. | $31.78 | 2024 | |
| Mauna Kea Technologies, INC. | $26.53 | 2024 | |
| Abbott Laboratories | $18.60 | 2023 | Supera |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic INC | $17.62 | 2022 | |
| Aesculap, INC. | $16.63 | 2020 | |
| Kci USA, INC. | $16.29 | 2023 | V.A.C. Dermatac, Activ.A.C., 3m Coban |
| Baudax Bio INC. | $15.46 | 2020 | |
| Becton, Dickinson and Company | $14.86 | 2024 | Venclose Maven Catheter |
| Teleflex LLC | $14.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Blass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.